{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T13:25:12Z","timestamp":1791897912436,"version":"4.3.4"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2023,4,8]],"date-time":"2023-04-08T00:00:00Z","timestamp":1680912000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,4,8]],"date-time":"2023-04-08T00:00:00Z","timestamp":1680912000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1245\/s10434-023-13367-w","type":"journal-article","created":{"date-parts":[[2023,4,8]],"date-time":"2023-04-08T15:02:29Z","timestamp":1680966149000},"page":"4123-4131","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Correlation of Mammographic Microcalcifications with Final Surgical Pathology After Neoadjuvant Chemotherapy for Breast Cancer"],"prefix":"10.1245","volume":"30","author":[{"given":"Riordan","family":"Azam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Belinda","family":"Curpen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Marie","family":"Mulligan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole Look","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,8]]},"reference":[{"issue":"2","key":"13367_CR1","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1177\/0284185118776491","volume":"60","author":"H Yim","year":"2019","unstructured":"Yim H, Ha T, Kang DK, Park SY, Jung Y, Kim TH. Change in microcalcifications on mammography after neoadjuvant chemotherapy in breast cancer patients: correlation with tumor response grade and comparison with lesion extent. Acta Radiol. 2019;60(2):131\u20139. https:\/\/doi.org\/10.1177\/0284185118776491.","journal-title":"Acta Radiol."},{"issue":"3","key":"13367_CR2","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1007\/s10549-018-4801-3","volume":"170","author":"W Haque","year":"2018","unstructured":"Haque W, Verma V, Hatch S, Suzanne Klimberg V, Brian Butler E, Teh BS. Response rates and pathologic complete response by breast cancer molecular subtype following neoadjuvant chemotherapy. Breast Cancer Res Treat. 2018;170(3):559\u201367. https:\/\/doi.org\/10.1007\/s10549-018-4801-3.","journal-title":"Breast Cancer Res Treat."},{"issue":"22","key":"13367_CR3","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1056\/NEJMoa1612645","volume":"376","author":"N Masuda","year":"2017","unstructured":"Masuda N, Lee SJ, Ohtani S, et al. Adjuvant capecitabine for breast cancer after preoperative chemotherapy. N Engl J Med. 2017;376(22):2147\u201359. https:\/\/doi.org\/10.1056\/NEJMoa1612645.","journal-title":"N Engl J Med."},{"issue":"7","key":"13367_CR4","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1056\/NEJMoa1814017","volume":"380","author":"G von Minckwitz","year":"2019","unstructured":"von Minckwitz G, Huang CS, Mano MS, et al. Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer. N Engl J Med. 2019;380(7):617\u201328. https:\/\/doi.org\/10.1056\/NEJMoa1814017.","journal-title":"N Engl J Med."},{"issue":"13","key":"13367_CR5","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1200\/JCO.20.03399","volume":"39","author":"LA Korde","year":"2021","unstructured":"Korde LA, Somerfield MR, Carey LA, et al. Neoadjuvant chemotherapy, endocrine therapy, and targeted therapy for breast cancer: ASCO guideline. J Clin Oncol. 2021;39(13):1485\u2013505. https:\/\/doi.org\/10.1200\/JCO.20.03399.","journal-title":"J Clin Oncol."},{"issue":"4","key":"13367_CR6","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.clbc.2016.12.010","volume":"17","author":"YL Gu","year":"2017","unstructured":"Gu YL, Pan SM, Ren J, Yang ZX, Jiang GQ. Role of magnetic resonance imaging in detection of pathologic complete remission in breast cancer patients treated with neoadjuvant chemotherapy: A Meta-analysis. Clinical Breast Cancer. 2017;17(4):245\u201355. https:\/\/doi.org\/10.1016\/j.clbc.2016.12.010.","journal-title":"Clinical Breast Cancer."},{"issue":"3","key":"13367_CR7","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1245\/s10434-015-4918-0","volume":"23","author":"B Schaefgen","year":"2016","unstructured":"Schaefgen B, Mati M, Sinn HP, et al. Can routine imaging after neoadjuvant chemotherapy in breast cancer predict pathologic complete response? Ann Surg Oncol. 2016;23(3):789\u201395. https:\/\/doi.org\/10.1245\/s10434-015-4918-0.","journal-title":"Ann Surg Oncol."},{"issue":"6","key":"13367_CR8","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1002\/jso.25663","volume":"120","author":"SF Sener","year":"2019","unstructured":"Sener SF, Sargent RE, Lee C, et al. MRI does not predict pathologic complete response after neoadjuvant chemotherapy for breast cancer. J Surg Oncol. 2019;120(6):903\u201310. https:\/\/doi.org\/10.1002\/jso.25663.","journal-title":"J Surg Oncol."},{"issue":"4","key":"13367_CR9","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1245\/s10434-014-4113-8","volume":"22","author":"BE Adrada","year":"2015","unstructured":"Adrada BE, Huo L, Lane DL, Arribas EM, Resetkova E, Yang W. Histopathologic correlation of residual mammographic microcalcifications after neoadjuvant chemotherapy for locally advanced breast cancer. Ann Surg Oncol. 2015;22(4):1111\u20137. https:\/\/doi.org\/10.1245\/s10434-014-4113-8.","journal-title":"Ann Surg Oncol."},{"issue":"1","key":"13367_CR10","doi-asserted-by":"publisher","first-page":"e82","DOI":"10.1016\/j.clbc.2019.05.015","volume":"20","author":"A Fushimi","year":"2020","unstructured":"Fushimi A, Kudo R, Takeyama H. Do decreased breast microcalcifications after neoadjuvant chemotherapy predict pathologic complete response? Clin Breast Cancer. 2020;20(1):e82\u20138. https:\/\/doi.org\/10.1016\/j.clbc.2019.05.015.","journal-title":"Clin Breast Cancer."},{"issue":"8","key":"13367_CR11","doi-asserted-by":"publisher","first-page":"641.e19","DOI":"10.1016\/j.crad.2020.03.024","volume":"75","author":"EY Kim","year":"2020","unstructured":"Kim EY, Do SI, Yun JS, et al. Preoperative evaluation of mammographic microcalcifications after neoadjuvant chemotherapy for breast cancer. Clin Radiol. 2020;75(8):641.e19-e27. https:\/\/doi.org\/10.1016\/j.crad.2020.03.024.","journal-title":"Clin Radiol."},{"issue":"10","key":"13367_CR12","doi-asserted-by":"publisher","first-page":"3310","DOI":"10.1245\/s10434-014-3914-0","volume":"21","author":"A Weiss","year":"2014","unstructured":"Weiss A, Lee KC, Romero Y, et al. Calcifications on mammogram do not correlate with tumor size after neoadjuvant chemotherapy. Ann Surg Oncol. 2014;21(10):3310\u20136. https:\/\/doi.org\/10.1245\/s10434-014-3914-0.","journal-title":"Ann Surg Oncol."},{"issue":"4","key":"13367_CR13","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1245\/s10434-015-4993-2","volume":"23","author":"YS Kim","year":"2016","unstructured":"Kim YS, Chang JM, Moon HG, Lee J, Shin SU, Moon WK. Residual mammographic microcalcifications and enhancing lesions on mri after neoadjuvant systemic chemotherapy for locally advanced breast cancer: correlation with histopathologic residual tumor size. Ann Surg Oncol. 2016;23(4):1135\u201342. https:\/\/doi.org\/10.1245\/s10434-015-4993-2.","journal-title":"Ann Surg Oncol."},{"issue":"8","key":"13367_CR14","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1016\/j.ejso.2017.04.011","volume":"43","author":"H Goldberg","year":"2017","unstructured":"Goldberg H, Zandbank J, Kent V, et al. Chemotherapy may eradicate ductal carcinoma in situ (DCIS) but not the associated microcalcifications. Eur J Surg Oncol. 2017;43(8):1415\u201320. https:\/\/doi.org\/10.1016\/j.ejso.2017.04.011.","journal-title":"Eur J Surg Oncol."},{"issue":"6","key":"13367_CR15","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1245\/s10434-016-5741-y","volume":"24","author":"Y Feliciano","year":"2017","unstructured":"Feliciano Y, Mamtani A, Morrow M, Stempel MM, Patil S, Jochelson MS. Do calcifications seen on mammography after neoadjuvant chemotherapy for breast cancer always need to be excised? Ann Surg Oncol. 2017;24(6):1492\u20138. https:\/\/doi.org\/10.1245\/s10434-016-5741-y.","journal-title":"Ann Surg Oncol."},{"issue":"4","key":"13367_CR16","doi-asserted-by":"publisher","first-page":"459","DOI":"10.4048\/jbc.2016.19.4.459","volume":"19","author":"GW Shin","year":"2016","unstructured":"Shin GW, Park YM, Yoon HK, et al. Increased malignant microcalcifications after neoadjuvant chemotherapy in advanced breast cancer. J Breast Cancer. 2016;19(4):459. https:\/\/doi.org\/10.4048\/jbc.2016.19.4.459.","journal-title":"J Breast Cancer."},{"issue":"5","key":"13367_CR17","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1213\/ANE.0000000000002864","volume":"126","author":"P Schober","year":"2018","unstructured":"Schober P, Boer C, Schwarte LA. Correlation coefficients: appropriate use and interpretation. Anesth Analg. 2018;126(5):1763\u20138. https:\/\/doi.org\/10.1213\/ANE.0000000000002864.","journal-title":"Anesth Analg."},{"issue":"1","key":"13367_CR18","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1186\/s12957-017-1263-8","volume":"15","author":"YY An","year":"2017","unstructured":"An YY, Kim SH, Kang BJ. Residual microcalcifications after neoadjuvant chemotherapy for locally advanced breast cancer: comparison of the accuracies of mammography and MRI in predicting pathological residual tumor. World J Surg Oncol. 2017;15(1):198. https:\/\/doi.org\/10.1186\/s12957-017-1263-8.","journal-title":"World J Surg Oncol."},{"issue":"5","key":"13367_CR19","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.2214\/ajr.181.5.1811275","volume":"181","author":"EL Rosen","year":"2003","unstructured":"Rosen EL, Blackwell KL, Baker JA, et al. Accuracy of MRI in the detection of residual breast cancer after neoadjuvant chemotherapy. Am J Roentgenol. 2003;181(5):1275\u201382. https:\/\/doi.org\/10.2214\/ajr.181.5.1811275.","journal-title":"Am J Roentgenol."},{"issue":"3","key":"13367_CR20","doi-asserted-by":"publisher","first-page":"868","DOI":"10.2214\/ajr.184.3.01840868","volume":"184","author":"E Yeh","year":"2005","unstructured":"Yeh E, Slanetz P, Kopans DB, et al. Prospective comparison of mammography, sonography, and MRI in patients undergoing neoadjuvant chemotherapy for palpable breast cancer. Am J Roentgenol. 2005;184(3):868\u201377. https:\/\/doi.org\/10.2214\/ajr.184.3.01840868.","journal-title":"Am J Roentgenol."},{"key":"13367_CR21","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.ejca.2015.10.010","volume":"52","author":"BEPJ Vriens","year":"2016","unstructured":"Vriens BEPJ, de Vries B, Lobbes MBI, et al. Ultrasound is at least as good as magnetic resonance imaging in predicting tumour size post-neoadjuvant chemotherapy in breast cancer. Eur J Cancer. 2016;52:67\u201376. https:\/\/doi.org\/10.1016\/j.ejca.2015.10.010.","journal-title":"Eur J Cancer."},{"issue":"11","key":"13367_CR22","doi-asserted-by":"publisher","first-page":"3149","DOI":"10.1245\/s10434-011-1912-z","volume":"18","author":"KP McGuire","year":"2011","unstructured":"McGuire KP, Toro-Burguete J, Dang H, et al. MRI staging after neoadjuvant chemotherapy for breast cancer: Does tumor biology affect accuracy? Ann Surg Oncol. 2011;18(11):3149\u201354. https:\/\/doi.org\/10.1245\/s10434-011-1912-z.","journal-title":"Ann Surg Oncol."},{"issue":"6","key":"13367_CR23","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.2214\/AJR.17.18323","volume":"210","author":"JR Scheel","year":"2018","unstructured":"Scheel JR, Kim E, Partridge SC, et al. MRI, clinical examination, and mammography for preoperative assessment of residual disease and pathologic complete response after neoadjuvant chemotherapy for breast cancer: ACRIN 6657 trial. Am J Roentgenol. 2018;210(6):1376\u201385. https:\/\/doi.org\/10.2214\/AJR.17.18323.","journal-title":"Am J Roentgenol."},{"issue":"1","key":"13367_CR24","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/clpt.2009.6810","volume":"86","author":"A Barker","year":"2009","unstructured":"Barker A, Sigman C, Kelloff G, Hylton N, Berry D, Esserman L. I-SPY 2: An adaptive breast cancer trial design in the setting of neoadjuvant chemotherapy. Clin Pharmacol Ther. 2009;86(1):97\u2013100. https:\/\/doi.org\/10.1038\/clpt.2009.6810.","journal-title":"Clin Pharmacol Ther."},{"issue":"9","key":"13367_CR25","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1007\/s00268-019-05032-9","volume":"43","author":"N Yu","year":"2019","unstructured":"Yu N, Leung VWY, Meterissian S. MRI performance in detecting pCR after neoadjuvant chemotherapy by molecular subtype of breast cancer. World J Surg. 2019;43(9):2254\u201361. https:\/\/doi.org\/10.1007\/s00268-019-05032-9.","journal-title":"World J Surg."},{"issue":"2","key":"13367_CR26","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1148\/radiol.2021203871","volume":"299","author":"SY Kim","year":"2021","unstructured":"Kim SY, Cho N, Choi Y, Lee SH, Ha SM, Kim ES, et al. Factors affecting pathologic complete response following neoadjuvant chemotherapy in breast cancer: development and validation of a predictive nomogram. Radiology. 2021;299(2):290\u2013300. https:\/\/doi.org\/10.1148\/radiol.2021203871.","journal-title":"Radiology."},{"key":"13367_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2022\/1218128","volume":"2022","author":"A Atoui","year":"2022","unstructured":"Atoui A, Bou Zerdan M, El Mahmoud A, Chamseddine N, Hamad L, Assi HI. Clinical significance of breast cancer molecular subtypes and Ki67 expression as a predictive value for pathological complete response following neoadjuvant chemotherapy: experience from a tertiary care center. Int J Breast Cancer. 2022;2022:1\u20136. https:\/\/doi.org\/10.1155\/2022\/1218128.","journal-title":"Int J Breast Cancer."},{"issue":"4","key":"13367_CR28","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/j.ejrad.2016.01.005","volume":"85","author":"L Heacock","year":"2016","unstructured":"Heacock L, Melsaether AN, Heller SL, et al. Evaluation of a known breast cancer using an abbreviated breast MRI protocol: Correlation of imaging characteristics and pathology with lesion detection and conspicuity. Eur J Radiol. 2016;85(4):815\u201323. https:\/\/doi.org\/10.1016\/j.ejrad.2016.01.005.","journal-title":"Eur J Radiol."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-023-13367-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-023-13367-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-023-13367-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T13:09:08Z","timestamp":1686229748000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-023-13367-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,8]]},"references-count":28,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["13367"],"URL":"https:\/\/doi.org\/10.1245\/s10434-023-13367-w","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,8]]},"assertion":[{"value":"27 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Riordan Azam, David Lim, Belinda Curpen, Anne-Marie Mulligan, and Nicole Look Hong have no disclosures to declare in relation to this manuscript.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}